investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide

Dennis Klinman

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

Keiran Smalley

Drug Discovery Center

All cancers but non-melanoma skin cancer

Weei-Chin Lin

The ATM/E2F1 Pathway in DNA Damage and Growth Control

All cancers but non-melanoma skin cancer

Dieter Haemmerich

In vivo Derived in Silico Model for DDS Optimization

Trachea, bronchus and lung

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Trachea, bronchus and lung

Jian-Yue Jin

A Synchronized Moving Grid (SMOG) System to Improve CBCT for IGRT and ART

All cancers but non-melanoma skin cancer

David Macpherson

Interrogation of MLL2 as a tumor suppressor gene in lung cancer

Trachea, bronchus and lung

Stephen Scwartz

EXPANDING SEER TO INCLUDE MOLECULAR PROFILING IN NON-SMALL CELL LUNG CANCER (NSCLC)

Trachea, bronchus and lung

Steven A Carr

Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers

All cancers but non-melanoma skin cancer

Sankar Mitra

Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genomes

All cancers but non-melanoma skin cancer

Radiation Oncology